Pipeline

Therapeutic Area
Therapeutic Area Project Category Indication Research Pre-clinical Phase I Phase II Phase III Remarks
Orphan Open
Innovation		 HL2356
(GX-H9)		 Bio-better Growth Hormone Deficiency in Adults       Biologics  
  • Collaborated with Genexine
Growth Hormone Deficiency in Pediatrics         BiologicsChina
Orphan/ Metabolism Open
Innovation		 RZ358 Bio Intravenous monoclonal antibody
for Congenital Hyperinsulinism		         Biologics
  • Rezolute: Licensor
  • Handok: Korea right for development and commercialization
RZ402 NCE
(New chemical entity)		 Oral Plasma Kallikrein Inhibitor
for Diabetic Macular Edema		       Chemical  
Oncology Handok
R&D		 HD-NC001 NCE  Dual-targeting inhibitor Solid cancer Chemical        
  • Collaborated with PimedBio
HD-NC002 Solid cancer Chemical        
HD-NC003 NCE  PROTAC Solid cancer Chemical        
  • Collaborated with BNJ Biopharma
HD-NC004 Solid cancer Chemical        
Open
Innovation		 HD-B001A Bispecific antibody Cancer       Biologics
  • ABL Bio: Licensor
  • Handok: Korea right, collaboration with Compass Therapeutics for global clinical trial phase 2,3
HL5101 NCE Solid cancer     Chemical    
  • Handok/CMG Pharma: Licensor
  • AUM Bioscience: Global right for development and commercialization excluding Korea
SBP-101 NCE
(New chemical entity)		 Melanoma, BTC, GBM     Chemical    
  • SPARK Biopharma: Licensor
  • Handok: Korea right for development and commercialization
ABL111 Bispecific antibody Solid cancer     Biologics    
  • ABL Bio: Licensor
  • Handok: Korea right for development and commercialization
ABL501     Biologics    
ABL503     Biologics    
  • ABL Bio: Licensor
  • Handok: Right of first negotiation for Korea
Derma SCM-AD Stem Cell Therapy Atopic Dermatitis       Biologics  
  • SCM Lifescience: Licensor
  • Handok: Korea right for development and commercialization
Medical Device
Therapeutic Area Project Category Indication Development Clinical Regulatory Approval Remarks
CV / Infection Open
Innovation		 RST Kit Diagnostics CV / Infection   Medical Device  
  • NB Postech: Licensor
  • Handok: Global commercialization right
Digital Health
Therapeutic Area Project Category Indication Discovery POC Pivotal Regulatory Commercial Remarks
CNS Open
Innovation		 WELT-I
(SleepCure)		 DTx Insomnia(Brand: SleepQ)         DTx
  • Welt: Licensor
  • Handok: Korea right for development and commercialization
WELT-A Alcoholism   DTx      
맨위로